open access

Vol 15, No 3 (2019)
Review paper
Published online: 2019-06-26
Get Citation

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Krzysztof Warzocha, Wojciech Homenda, Andrzej Pluta, Tomasz Sacha, Maria Cioch, Marek Dudziński, Dorota Krochmalczyk, Joanna Góra-Tybor, Ilona Seferyńska, Monika Joks, Marta Sobas
DOI: 10.5603/OCP.2019.0021
·
Oncol Clin Pract 2019;15(3):167-179.

open access

Vol 15, No 3 (2019)
REVIEW ARTICLES
Published online: 2019-06-26

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Journal

Oncology in Clinical Practice

Issue

Vol 15, No 3 (2019)

Article type

Review paper

Pages

167-179

Published online

2019-06-26

DOI

10.5603/OCP.2019.0021

Bibliographic record

Oncol Clin Pract 2019;15(3):167-179.

Authors

Krzysztof Warzocha
Wojciech Homenda
Andrzej Pluta
Tomasz Sacha
Maria Cioch
Marek Dudziński
Dorota Krochmalczyk
Joanna Góra-Tybor
Ilona Seferyńska
Monika Joks
Marta Sobas

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl